News of the WeekGenomics

A Second Private Genome Project

Science  21 Aug 1998:
Vol. 281, Issue 5380, pp. 1121
DOI: 10.1126/science.281.5380.1121a

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Incyte Pharmaceuticals, Inc., a genetic data company in Palo Alto, California, announced this week that it plans to invest $200 million over the next 2 years to sequence the protein coding regions of the human genome. It will also hunt for simple variations in the genetic code--also known as single nucleotide polymorphisms, or SNPs--and locate them and about 100,000 human genes on a computerized map. These data will be kept in a proprietary trove, available only to those willing to pay Incyte's stiff fees. This project could rival the controversial sequencing and SNP-collection effort announced earlier this year by Perkin-Elmer Corp. of Norwalk, Connecticut, and J. Craig Venter of The Institute for Genomic Research (Science, 15 May, p. 994).